Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.



Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global


None – the final white paper should be out Q4 2024

Status
colourBlue
titleCurrent Status
Q4 2024

Q2 2025

  • Complete validation and publication of Stage 1 R programs.
  • Complete full draft white paper for Stage 2.



Q4 2023

Objectives & Deliverables

Timelines 
White PaperQ4 2023

Finalise Stage 1 2 of draft White Paper